🔴 Viking Therapeutics is trading 4.3% down today as sector risk-off sentiment weighs on shares

Viking Therapeutics is trading 4.3% down at $31.70 as broad biotech sector weakness weighs on the stock.

• The decline extends a week-long slide following the company's late-July earnings report and obesity pipeline update.
• The move tracks a sharp drop in the broader biotech space, with the XBI ETF falling over 3%.
• Today's pressure appears driven by sector-wide risk-off sentiment rather than any new, company-specific headlines.